SUBCELLULAR LOCALIZATION
| plasma membrane
|
| intracellular
|
|
| intracellular,cytoplasm,organelle,membrane
|
|
| intracellular,cytoplasm,organelle,endoplasmic reticulum
|
|
| intracellular,nucleus,nucleoplasm
|
| text
| membrane-associated colocalized with PS2 |
|
shifting from nucleus to perinuclear compartment when coexpressed with M17S2 |
|
localizes primarily to the sarcolemma in myocardium, where it anchors calcineurin to control its activation in coordination with the L-type Ca2+ channel  |
|
localizes to the plasma membrane in fibroblasts, human venous endothelial cells  |
| basic FUNCTION
| playing a role in kinase-phosphatase regulation of DNA and joining |
|
converting the inactive conformation of integrin alpha-IIB/beta 3 to an active form through the binding to the integrin cytoplasmic domain |
|
playing a dynamic role in signaling, cell death and Alzheimer's disease |
|
negative regulator for PLK2 activity |
|
regulates platelet aggregation in hemostasis through a specific interaction with the alphaIIb cytoplasmic domain of platelet integrin alphaIIbbeta3 |
|
functions as a Ca2+-sensitive negative regulator of MAP3K5-mediated signaling events  |
|
binds many other proteins including presenilin 2, DNA-dependent protein kinase, the polo-like kinases PLK3 and PLK2  |
|
having a function working as a Ca2+-sensitive antagonist of stress-induced signaling events  |
|
functions as a previously undescribed regulator of cardiac hypertrophy through its ability to regulate the association of calcineurin with the sarcolemma and its activation  |
|
regulator of calcineurin-NFAT signaling and cardiac hypertrophy  |
|
necessary for pathological but not physiological hypertrophy and contributes to cardiac dysfunction during pressure overload  |
|
unique regulator of pathological cardiac hypertrophy and calcineurin-NFAT signaling in cardiac myocytes  |
|
required for permitting activation of calcineurin during maladaptive cardiac hypertrophy  |